Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Non-cash Items: 2013-2025

Historic Non-cash Items for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to $4.8 million.

  • Amphastar Pharmaceuticals' Non-cash Items fell 97.17% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 97.17%. This contributed to the annual value of $95.3 million for FY2024, which is 70.87% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Non-cash Items stood at $4.8 million for Q3 2025, which was down 76.16% from $20.0 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Non-cash Items ranged from a high of $327.2 million in Q4 2023 and a low of $500,000 during Q3 2021.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Non-cash Items value was $46.4 million (recorded in 2025), while the average stood at $103.6 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first tumbled by 98.64% in 2021, then skyrocketed by 17,627.80% in 2022.
  • Over the past 5 years, Amphastar Pharmaceuticals' Non-cash Items (Quarterly) stood at $500,000 in 2021, then skyrocketed by 1,010.14% to $5.6 million in 2022, then soared by 5,793.94% to $327.2 million in 2023, then slumped by 70.87% to $95.3 million in 2024, then plummeted by 97.17% to $4.8 million in 2025.
  • Its last three reported values are $4.8 million in Q3 2025, $20.0 million for Q2 2025, and $46.4 million during Q1 2025.